- MYL has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $160.9 million.
- MYL is up 2.8% today from today's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in MYL with the Ticky from Trade-Ideas. See the FREE profile for MYL NOW at Trade-Ideas More details on MYL: Mylan Inc., a pharmaceutical company, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. It operates in two segments, Generics and Specialty. MYL has a PE ratio of 31.0. Currently there are 9 analysts that rate Mylan a buy, no analysts rate it a sell, and 2 rate it a hold. The average volume for Mylan has been 4.1 million shares per day over the past 30 days. Mylan has a market cap of $18.7 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.16 and a short float of 7.3% with 9.72 days to cover. Shares are up 16.8% year-to-date as of the close of trading on Thursday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.